Crystalline form i rosuvastatin zinc salt
The present invention relates to crystalline Form I rosuvastatin zinc (2:1) salt, method of preparation thereof and use thereof as pharmaceutically active ingredient for the treatment of diseases related to lipid metabolism including hyperlipoproteinemia, hypercholesteremia, dyslipidemia and atheros...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SLEGEL PETER CLEMENTIS GYOERGY RUZSICS GYOERGY VOLK BALAZS HOFFMANNE FEKETE VALERIA SZENT-KIRALLYI ZSUZSANNA IMRE JANOS KOVANYINE LAX GYOERGYI NAGY KALMAN KESZTHELYI ADRIENN BARTHA FEREN KRASZNAI GYOERGY SIMIG GYULA BARKOCZY J. ZSEF MOROVJAN GYOERGY KAPUI IMRE |
| description | The present invention relates to crystalline Form I rosuvastatin zinc (2:1) salt, method of preparation thereof and use thereof as pharmaceutically active ingredient for the treatment of diseases related to lipid metabolism including hyperlipoproteinemia, hypercholesteremia, dyslipidemia and atherosclerosis. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN102548971A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN102548971A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN102548971A3</originalsourceid><addsrcrecordid>eNrjZNB0LqosLknMycnMS1VIyy_KVchUKMovLi1LBIqWZOYpVGXmJSsUJ-aU8DCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSSeGc_QwMjUxMLS3NDR2Ni1AAAIo0o_A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Crystalline form i rosuvastatin zinc salt</title><source>esp@cenet</source><creator>SLEGEL PETER ; CLEMENTIS GYOERGY ; RUZSICS GYOERGY ; VOLK BALAZS ; HOFFMANNE FEKETE VALERIA ; SZENT-KIRALLYI ZSUZSANNA ; IMRE JANOS ; KOVANYINE LAX GYOERGYI ; NAGY KALMAN ; KESZTHELYI ADRIENN ; BARTHA FEREN ; KRASZNAI GYOERGY ; SIMIG GYULA ; BARKOCZY J. ZSEF ; MOROVJAN GYOERGY ; KAPUI IMRE</creator><creatorcontrib>SLEGEL PETER ; CLEMENTIS GYOERGY ; RUZSICS GYOERGY ; VOLK BALAZS ; HOFFMANNE FEKETE VALERIA ; SZENT-KIRALLYI ZSUZSANNA ; IMRE JANOS ; KOVANYINE LAX GYOERGYI ; NAGY KALMAN ; KESZTHELYI ADRIENN ; BARTHA FEREN ; KRASZNAI GYOERGY ; SIMIG GYULA ; BARKOCZY J. ZSEF ; MOROVJAN GYOERGY ; KAPUI IMRE</creatorcontrib><description>The present invention relates to crystalline Form I rosuvastatin zinc (2:1) salt, method of preparation thereof and use thereof as pharmaceutically active ingredient for the treatment of diseases related to lipid metabolism including hyperlipoproteinemia, hypercholesteremia, dyslipidemia and atherosclerosis.</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120704&DB=EPODOC&CC=CN&NR=102548971A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120704&DB=EPODOC&CC=CN&NR=102548971A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SLEGEL PETER</creatorcontrib><creatorcontrib>CLEMENTIS GYOERGY</creatorcontrib><creatorcontrib>RUZSICS GYOERGY</creatorcontrib><creatorcontrib>VOLK BALAZS</creatorcontrib><creatorcontrib>HOFFMANNE FEKETE VALERIA</creatorcontrib><creatorcontrib>SZENT-KIRALLYI ZSUZSANNA</creatorcontrib><creatorcontrib>IMRE JANOS</creatorcontrib><creatorcontrib>KOVANYINE LAX GYOERGYI</creatorcontrib><creatorcontrib>NAGY KALMAN</creatorcontrib><creatorcontrib>KESZTHELYI ADRIENN</creatorcontrib><creatorcontrib>BARTHA FEREN</creatorcontrib><creatorcontrib>KRASZNAI GYOERGY</creatorcontrib><creatorcontrib>SIMIG GYULA</creatorcontrib><creatorcontrib>BARKOCZY J. ZSEF</creatorcontrib><creatorcontrib>MOROVJAN GYOERGY</creatorcontrib><creatorcontrib>KAPUI IMRE</creatorcontrib><title>Crystalline form i rosuvastatin zinc salt</title><description>The present invention relates to crystalline Form I rosuvastatin zinc (2:1) salt, method of preparation thereof and use thereof as pharmaceutically active ingredient for the treatment of diseases related to lipid metabolism including hyperlipoproteinemia, hypercholesteremia, dyslipidemia and atherosclerosis.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB0LqosLknMycnMS1VIyy_KVchUKMovLi1LBIqWZOYpVGXmJSsUJ-aU8DCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSSeGc_QwMjUxMLS3NDR2Ni1AAAIo0o_A</recordid><startdate>20120704</startdate><enddate>20120704</enddate><creator>SLEGEL PETER</creator><creator>CLEMENTIS GYOERGY</creator><creator>RUZSICS GYOERGY</creator><creator>VOLK BALAZS</creator><creator>HOFFMANNE FEKETE VALERIA</creator><creator>SZENT-KIRALLYI ZSUZSANNA</creator><creator>IMRE JANOS</creator><creator>KOVANYINE LAX GYOERGYI</creator><creator>NAGY KALMAN</creator><creator>KESZTHELYI ADRIENN</creator><creator>BARTHA FEREN</creator><creator>KRASZNAI GYOERGY</creator><creator>SIMIG GYULA</creator><creator>BARKOCZY J. ZSEF</creator><creator>MOROVJAN GYOERGY</creator><creator>KAPUI IMRE</creator><scope>EVB</scope></search><sort><creationdate>20120704</creationdate><title>Crystalline form i rosuvastatin zinc salt</title><author>SLEGEL PETER ; CLEMENTIS GYOERGY ; RUZSICS GYOERGY ; VOLK BALAZS ; HOFFMANNE FEKETE VALERIA ; SZENT-KIRALLYI ZSUZSANNA ; IMRE JANOS ; KOVANYINE LAX GYOERGYI ; NAGY KALMAN ; KESZTHELYI ADRIENN ; BARTHA FEREN ; KRASZNAI GYOERGY ; SIMIG GYULA ; BARKOCZY J. ZSEF ; MOROVJAN GYOERGY ; KAPUI IMRE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN102548971A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SLEGEL PETER</creatorcontrib><creatorcontrib>CLEMENTIS GYOERGY</creatorcontrib><creatorcontrib>RUZSICS GYOERGY</creatorcontrib><creatorcontrib>VOLK BALAZS</creatorcontrib><creatorcontrib>HOFFMANNE FEKETE VALERIA</creatorcontrib><creatorcontrib>SZENT-KIRALLYI ZSUZSANNA</creatorcontrib><creatorcontrib>IMRE JANOS</creatorcontrib><creatorcontrib>KOVANYINE LAX GYOERGYI</creatorcontrib><creatorcontrib>NAGY KALMAN</creatorcontrib><creatorcontrib>KESZTHELYI ADRIENN</creatorcontrib><creatorcontrib>BARTHA FEREN</creatorcontrib><creatorcontrib>KRASZNAI GYOERGY</creatorcontrib><creatorcontrib>SIMIG GYULA</creatorcontrib><creatorcontrib>BARKOCZY J. ZSEF</creatorcontrib><creatorcontrib>MOROVJAN GYOERGY</creatorcontrib><creatorcontrib>KAPUI IMRE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SLEGEL PETER</au><au>CLEMENTIS GYOERGY</au><au>RUZSICS GYOERGY</au><au>VOLK BALAZS</au><au>HOFFMANNE FEKETE VALERIA</au><au>SZENT-KIRALLYI ZSUZSANNA</au><au>IMRE JANOS</au><au>KOVANYINE LAX GYOERGYI</au><au>NAGY KALMAN</au><au>KESZTHELYI ADRIENN</au><au>BARTHA FEREN</au><au>KRASZNAI GYOERGY</au><au>SIMIG GYULA</au><au>BARKOCZY J. ZSEF</au><au>MOROVJAN GYOERGY</au><au>KAPUI IMRE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Crystalline form i rosuvastatin zinc salt</title><date>2012-07-04</date><risdate>2012</risdate><abstract>The present invention relates to crystalline Form I rosuvastatin zinc (2:1) salt, method of preparation thereof and use thereof as pharmaceutically active ingredient for the treatment of diseases related to lipid metabolism including hyperlipoproteinemia, hypercholesteremia, dyslipidemia and atherosclerosis.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN102548971A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Crystalline form i rosuvastatin zinc salt |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T23%3A28%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SLEGEL%20PETER&rft.date=2012-07-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN102548971A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |